Stay updated on Nivolumab Plus SBRT in Metastatic RCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition appears above the ClinicalTrials.gov page, and the site revision changes from v3.7.1 to v3.7.2. The study record remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-20T20:56:30.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T21:51:09.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error replacing the study record content, with a standard site header/footer and no trial details visible.
    Difference
    17%
    Check dated 2026-09-22T22:06:46.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.7.0, replacing the previous v3.6.6. This reflects a new version of the page's documentation rather than a substantive change to the study data or details.
    Difference
    0.1%
    Check dated 2026-09-15T22:26:56.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now displays the revision label v3.6.6, replacing the previous v3.6.5.
    Difference
    0.1%
    Check dated 2026-09-01T17:54:43.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Revision tag on the page updated from v3.6.4 to v3.6.5, signaling a new internal revision of the Study Details page. No changes to study data, eligibility criteria, or results are indicated by this update.
    Difference
    0.1%
    Check dated 2026-08-11T19:34:40.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus SBRT in Metastatic RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.